Sign in

Private company

Invitae

Logo: invitae.com4

American medical laboratories services company based in San Francisco1

In its 2023 annual report the company says: “We offer genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. We also utilize digital health solutions to improve ease-of-use and to deliver actionable information about risk, prevention, treatment, and monitoring.”70 It was founded in 2010.1 It ceased to exist in 2024.1

Last updated Oct 21, 2026.

Overview

2010Founded1
  • IndustryServices-Medical Laboratories1
  • HeadquartersSan Francisco1
  • Websitewww.invitae.com/en
  • Legal formDelaware corporation1
  • Incorporated inDE5
  • Business address1400 16Th Street, San Francisco, Ca 941035
  • Filer categoryLarge accelerated filer5
  • LEI549300MYI59DZW1WIX923
  • StatusActive3
  • LEI statusLapsed (not renewed)3
  • Registered addressC/O The Corporation Trust Company, 19801 Wilmington, United States3
  • Registered withDivision of Corporations, Department of State, 47410493

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-604.0%Operating margin6
-600.4%Net margin7
12.1%Revenue growth, 20226
-3044.1%Return on equity6
-$546.3MFree cash flow7

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue45¢$417.3M
  • Research and development44¢$402.1M
  • Interest6¢$56.7M
  • Income tax5¢$44.9M

Out of $516.3M in revenue.67 The company lost money this year.

Financial statements

Revenue8910116$516.3M in 2022+1961% since 2016
0$200.0M$400.0M$600.0M2016: $25.0M$25.0M20162017: $68.2M$68.2M2017+172%2018: $147.7M$147.7M2018+117%2019: $216.8M$216.8M2019+47%2020: $279.6M$279.6M2020+29%2021: $460.4M$460.4M2021+65%2022: $516.3M$516.3M2022+12%
Operating income8910116-$3.1B in 2022+3013% since 2016
-$4.0B-$3.0B-$2.0B-$1.0B02016: -$100.2M-$100.2M20162017: -$121.3M-$121.3M2017+21%2018: -$122.6M-$122.6M2018+1%2019: -$244.1M-$244.1M2019+99%2020: -$652.2M-$652.2M2020+167%2021: -$391.6M-$391.6M2021−40%2022: -$3.1B-$3.1B2022+696%
Net income8910117-$3.1B in 2022+2992% since 2016
-$4.0B-$3.0B-$2.0B-$1.0B02016: -$100.3M-$100.3M20162017: -$123.4M-$123.4M2017+23%2018: -$129.4M-$129.4M2018+5%2019: -$242.0M-$242.0M2019+87%2020: -$602.2M-$602.2M2020+149%2021: -$379.0M-$379.0M2021−37%2022: -$3.1B-$3.1B2022+718%
Fiscal year2016201720182019202020212022
Revenue$25.0M8$68.2M9$147.7M10$216.8M11$279.6M6$460.4M6$516.3M6
Cost of revenue$27.9M8$50.1M9$80.1M10$118.1M11$198.3M6$348.7M6$417.3M6
Research and development$44.6M8$46.5M9$63.5M10$141.5M11$240.6M6$416.1M6$402.1M6
Operating expenses$852.1M6$3.6B6
Operating income-$100.2M8-$121.3M9-$122.6M10-$244.1M11-$652.2M6-$391.6M6-$3.1B6
Interest$421.0K8$3.7M9$7.0M10$12.4M11$29.8M6$49.9M6$56.7M6
Income before tax-$415.9M6-$3.2B6
Income tax$08-$1.9M9-$2.8M10-$18.4M11-$112.1M6-$36.9M6-$44.9M6
Net income-$100.3M8-$123.4M9-$129.4M10-$242.0M11-$602.2M7-$379.0M7-$3.1B7
Earnings per share-$2.6611-$4.476-$1.806-$13.186
Earnings per share (diluted)-$2.6611-$4.476-$1.806-$13.186
Shares (weighted, basic)210.9M shares6235.7M shares6
Shares (weighted, diluted)210.9M shares6235.7M shares6

Compare Invitae with another company

Corporate structure

Invitae sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Invitae

  • Invitae San Francisco, California, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Invitae reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$179.3M6 Dec 31, 2022$163.0M6 Dec 31, 2021+10.0%
Accumulated depreciation$70.6M6 Dec 31, 2022$48.3M6 Dec 31, 2021+46.1%
Property and equipment, net$108.7M6 Dec 31, 2022$114.7M6 Dec 31, 2021−5.2%
Operating-lease assets (leased space)$106.6M6 Dec 31, 2022$121.2M6 Dec 31, 2021−12.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$257.5M6 Dec 31, 2022$923.2M6 Dec 31, 2021−72.1%
Marketable securities, current$289.6M6 Dec 31, 2022$122.1M6 Dec 31, 2021+137.2%
Debt securities available for sale$289.6M6 Dec 31, 2022$122.1M6 Dec 31, 2021+137.2%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$06 Dec 31, 2022$2.3B6 Dec 31, 2021−100.0%
Intangible assets, net (excluding goodwill)$1.0B6 Dec 31, 2022$1.2B6 Dec 31, 2021−14.8%
Accumulated amortization$207.7M6 Dec 31, 2022$99.2M6 Dec 31, 2021+109.3%
Finite-lived intangibles, net$1.0B6 Dec 31, 2022$645.6M11 Dec 31, 2021+56.8%

Inventory

ItemLatestA year beforeChange
Inventory, total$30.4M6 Dec 31, 2022$33.5M6 Dec 31, 2021−9.3%
Raw materials$30.0M6 Dec 31, 2022$27.2M6 Dec 31, 2021+10.4%
Work in process$382.0K6 Dec 31, 2022$5.3M6 Dec 31, 2021−92.8%
Finished goods$12.0K6 Dec 31, 2022$996.0K6 Dec 31, 2021−98.8%

Leadership

Who has led Invitae, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Randal W. Scott2015–2016
  2. Sean E. George2017–2022
  3. Kenneth D. Knight2022–2023

Chair

  1. Randal W. Scott2015–2019

President

  1. Sean E. George2015–2022

Chief financial officer

  1. E. Lee Bendekgey2015–2017
  2. Shelly D. Guyer2017–2021
  3. Yafei Wen2021–2023
  4. Ana J. Schrank2023

Chief operating officer

  1. Sean E. George2015–2016
  2. E. Lee Bendekgey2018–2020
  3. Kenneth D. Knight2020–2022
  4. David Sholehvar2023
201520202025
Board members and other officers (19)

Former names

  • Locus Development IncSep 15, 2010 to Mar 29, 20115

Timeline

  1. Aug 8, 20248-K Bankruptcy or receivership; Completed an acquisition or sale; Change to shareholders' rights43
  2. Jul 31, 20248-K Regulation FD disclosure44
  3. Jul 1, 20248-K Regulation FD disclosure45
  4. Jun 4, 20248-K Regulation FD disclosure46
  5. May 2, 20248-K Entered a material agreement; Regulation FD disclosure47
  6. Apr 4, 20248-K Regulation FD disclosure48
  7. Mar 6, 20248-K Results of operations; Regulation FD disclosure49
  8. Feb 14, 20248-K Entered a material agreement; Bankruptcy or receivership; Debt or obligation accelerated50
  9. Feb 6, 20248-K Listing notice or transfer51
  10. Jan 24, 20248-K Exit or restructuring costs52
  11. Jan 22, 20248-K Entered a material agreement; Completed an acquisition or sale; Exit or restructuring costs53
  12. Jan 18, 20248-K Executive or director change54
  13. 2024Dissolved Dissolved1
  14. Jul 19, 2022New chief executive Kenneth D. Knight becomes CEO15
  15. Feb 7, 2017New chief executive Sean E. George becomes CEO16
  16. Feb 11, 2015New chief executive Randal W. Scott becomes CEO17
  17. 2010Founded Founded1

Calendar

When it reported results

  1. Mar 6, 2024Reported quarterly or annual results49
  2. Nov 8, 2023Reported quarterly or annual results55
  3. Aug 8, 2023Reported quarterly or annual results56
  4. May 9, 2023Reported quarterly or annual results57
  5. Feb 28, 2023Reported quarterly or annual results58
  6. Jan 10, 2023Reported quarterly or annual results59
  7. Nov 8, 2022Reported quarterly or annual results60
  8. Aug 9, 2022Reported quarterly or annual results61

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

184 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 52 major events, 74 insider forms, 21 large holders, 28 other. The latest 20:

  1. Jan 10, 2025SCHEDULE 13G/A EDGAR
  2. Aug 8, 20248-K EDGAR
  3. Jul 31, 20248-K EDGAR
  4. Jul 1, 20248-K EDGAR
  5. Jun 4, 20248-K EDGAR
  6. May 2, 20248-K EDGAR
  7. Apr 4, 20248-K EDGAR
  8. Mar 6, 20248-K EDGAR
  9. Feb 14, 20248-K EDGAR
  10. Feb 13, 2024SC 13G/A EDGAR
  11. Feb 13, 2024SC 13G/A SCHEDULE 13G/A EDGAR
  12. Feb 6, 20248-K EDGAR
  13. Feb 5, 2024SC 13G/A AMENDMENT NO. 4 EDGAR
  14. Jan 29, 2024SC 13G/A EDGAR
  15. Jan 29, 2024SC 13G/A EDGAR
  16. Jan 24, 20248-K/A EDGAR
  17. Jan 22, 20248-K EDGAR
  18. Jan 18, 20248-K EDGAR
  19. Jan 12, 20248-K/A EDGAR
  20. Dec 21, 20234 EDGAR

The 184 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

33 open-market trades by officers, directors and large owners since October 2021: 0 buys and 33 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 13, 2023Nussbaum Robert LChief Medical OfficerSale7,086$1.38$9.8KForm 4
Jun 13, 2023Brida ThomasSee RemarksSale7,079$1.38$9.8KForm 4
May 16, 2023Wen YafeiChief Financial OfficerSale43,452$1.20$52.1KForm 4
May 16, 2023Knight Kenneth D.Chief Executive OfficerSale45,432$1.20$54.5KForm 4
May 16, 2023Nussbaum Robert LChief Medical OfficerSale26,476$1.20$31.8KForm 4
May 16, 2023Wen YafeiChief Financial OfficerSale43,452$1.99$86.5KForm 4
May 16, 2023WERNER ROBERT F.Chief Accounting OfficerSale21,559$1.20$25.9KForm 4
May 16, 2023Brida ThomasSee RemarksSale26,476$1.20$31.8KForm 4
Mar 13, 2023Brida ThomasSee RemarksSale2,625$1.41$3.7KForm 4
Mar 13, 2023Nussbaum Robert LChief Medical OfficerSale2,625$1.41$3.7KForm 4
Mar 13, 2023Wen YafeiChief Financial OfficerSale2,625$1.41$3.7KForm 4
Mar 13, 2023Knight Kenneth D.Chief Executive OfficerSale1,853$1.41$2.6KForm 4
Dec 19, 2022George Sean EDirectorSale11,163$2.08$23.2KForm 4
Dec 16, 2022George Sean EDirectorSale44,816$2.04$91.4KForm 4
Aug 25, 2022WERNER ROBERT F.Chief Accounting OfficerSale1,350$3.45$4.7KForm 4
Aug 16, 2022Brida ThomasSee RemarksSale7,048$4.55$32.1KForm 4
Aug 16, 2022Nussbaum Robert LChief Medical OfficerSale7,048$4.55$32.1KForm 4
Aug 16, 2022George Sean EDirectorSale22,085$4.55$100.5KForm 4
Aug 16, 2022WERNER ROBERT F.Chief Accounting OfficerSale3,252$4.55$14.8KForm 4
May 19, 2022WERNER ROBERT F.Chief Accounting OfficerSale2,746$3.40$9.3KForm 4

All 33 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Invitae is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARInvitae Corp2
  • CIK0001501134
  • Employer ID (EIN)27-17018982
  • Filer statusLarge accelerated filer2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)8071 Services-Medical Laboratories2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business address1400 16Th Street, San Francisco, CA 941032
  • Phone(415) 374-77822
  • Shares outstanding286,492,840 as of Nov 6, 20237
  • Public float$569.8M as of Jun 30, 20226
  • On EDGAR sinceSep 15, 20102
  • Filings812 in all: 4 (322), 8-K (149), SC 13G/A (54), 10-Q (27), 3 (27), SC 13G (21), CORRESP (17), S-8 (16)2
    All 50 form types

    S-3ASR (13), UPLOAD (13), 8-K/A (12), EFFECT (12), 424B3 (11), 424B5 (11), 4/A (10), 10-K (9), 425 (9), D (8), DEF 14A (7), DEFA14A (7), POS AM (5), S-3 (5), SC TO-T/A (4), SEC STAFF LETTER (4), 10-K/A (3), S-4 (3), S-4/A (3), 424B2 (2), DRSLTR (2), POSASR (2), PRE 14A (2), S-1/A (2), S-8 POS (2), SC 13D/A (2), 144 (1), 25-NSE (1), 424B4 (1), 424B7 (1), 8-A12B (1), 8-A12B/A (1), ARS (1), CERTNYS (1), CT ORDER (1), DRS (1), DRS/A (1), S-1 (1), S-1MEF (1), SC 13D (1), SC TO-T (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) Feb 28, 2023
    Quarterly report (10-Q) Nov 8, 2023
    Proxy statement (DEF 14A) Apr 19, 2023
    Latest 8-K (8-K) Aug 8, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
    Company websiteInvitae logo
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70